These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26839166)

  • 1. Fibrinogen and the Severity of Coronary Atherosclerosis among Adults with and without Statin Treatment: Lipid as a mediator.
    Zhang Y; Zhu CG; Guo YL; Li S; Xu RX; Dong Q; Li JJ
    Heart Lung Circ; 2016 Jun; 25(6):558-67. PubMed ID: 26839166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Lipids, Mean Platelet Volume, and the Severity of Coronary Artery Disease Among Chinese Adults: A Mediation Analysis.
    Yao Y; Li X; Wang Z; Ji Q; Xu Q; Yan Y; Lv Q
    Front Cardiovasc Med; 2022; 9():753171. PubMed ID: 35174229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and traditional lipid-related biomarkers and their combinations in predicting coronary severity.
    Li S; Guo YL; Zhao X; Zhang Y; Zhu CG; Wu NQ; Xu RX; Qing P; Gao Y; Li XL; Sun J; Liu G; Dong Q; Li JJ
    Sci Rep; 2017 Mar; 7(1):360. PubMed ID: 28336922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher fibrinogen level is independently linked with the presence and severity of new-onset coronary atherosclerosis among Han Chinese population.
    Zhang Y; Zhu CG; Guo YL; Xu RX; Li S; Dong Q; Li JJ
    PLoS One; 2014; 9(11):e113460. PubMed ID: 25426943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-HDL-C is a Better Predictor for the Severity of Coronary Atherosclerosis Compared with LDL-C.
    Zhang Y; Wu NQ; Li S; Zhu CG; Guo YL; Qing P; Gao Y; Li XL; Liu G; Dong Q; Li JJ
    Heart Lung Circ; 2016 Oct; 25(10):975-81. PubMed ID: 27634241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
    Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography.
    Song Y; Yang Y; Zhang J; Wang Y; He W; Zhang X; Zhu J; Lu Z
    Lipids Health Dis; 2015 Nov; 14():150. PubMed ID: 26582246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.
    Puri R; Nissen SE; Shao M; Uno K; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
    Am J Cardiol; 2014 Nov; 114(10):1465-72. PubMed ID: 25282317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the correlation between blood lipid levels and the severity of coronary atherosclerosis in a Chinese population sample.
    Jin Z; Zhang Y; Chen J; Zhu J; Zhang F; Qiu Y; Zhao L
    Acta Cardiol; 2006 Dec; 61(6):603-6. PubMed ID: 17205916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma fatty acid alteration with the severity of coronary artery disease lesions in Tunisian patients.
    Hadj Ahmed S; Kaoubaa N; Kharroubi W; Zarrouk A; Najjar MF; Batbout F; Gamra H; Lizard G; Hammami M
    Lipids Health Dis; 2017 Aug; 16(1):154. PubMed ID: 28806974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of C-reactive protein levels to presence, extent, and severity of angiographic coronary artery disease.
    Auer J; Rammer M; Berent R; Weber T; Lassnig E; Eber B
    Indian Heart J; 2002; 54(3):284-8. PubMed ID: 12216925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the relationship between passive smoking and blood lipids, fibrinogen and viscosity among women who never smoke].
    He Y; Jiang B; Wan ZH; Zheng QS; Li LS; Li LS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Dec; 28(12):1167-70. PubMed ID: 18476573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of lipoprotein (a) concentration with the extent of coronary artery disease in patients on lipid lowering therapy.
    Malek F; Dvorak J; Svitil J; Skalnikova V; Mates M; Kmonicek P; Formanek P; Aschermann O; Kopriva K; Neuzil P
    Neuro Endocrinol Lett; 2012; 33 Suppl 2():55-9. PubMed ID: 23183511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease.
    Li S; Zhang Y; Xu RX; Guo YL; Zhu CG; Wu NQ; Qing P; Liu G; Dong Q; Li JJ
    Ann Med; 2015; 47(5):386-93. PubMed ID: 26153823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body iron stores and coronary atherosclerosis assessed by coronary angiography.
    Auer J; Rammer M; Berent R; Weber T; Lassnig E; Eber B
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):285-90. PubMed ID: 12616808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.